Response to measles-mumps-rubella vaccine in children on dialysis

Pediatr Nephrol. 1992 Mar;6(2):187-9. doi: 10.1007/BF00866312.

Abstract

Ten children receiving maintenance dialysis were immunized with the standard dose of measles-mumps-rubella vaccine between 15 and 33 months of age. Immune responses to vaccination were determined using commercially available enzyme-linked immunosorbent assays for measles, mumps, and rubella viruses. Eight children responded to measles vaccine, 5 to mumps vaccine, 8 to rubella vaccine, and only 3 children to all three vaccines, compared with a seroconversion rate of over 90% to all three vaccines in healthy children (P less than 0.0001). We contend that the relatively poor immunocompetence of our dialysis patients explains their less than optimal vaccine response and suggest that children vaccinated while undergoing dialysis be tested to confirm serological evidence of immunity.

MeSH terms

  • Antibodies, Viral / biosynthesis*
  • Child, Preschool
  • Drug Combinations
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Humans
  • Immunization*
  • Infant
  • Kidney Failure, Chronic / immunology
  • Male
  • Measles / immunology
  • Measles / prevention & control
  • Measles Vaccine / administration & dosage
  • Measles Vaccine / immunology*
  • Measles-Mumps-Rubella Vaccine
  • Mumps / immunology
  • Mumps / prevention & control
  • Mumps Vaccine / administration & dosage
  • Mumps Vaccine / immunology*
  • Renal Dialysis*
  • Retrospective Studies
  • Rubella / immunology
  • Rubella / prevention & control
  • Rubella Vaccine / administration & dosage
  • Rubella Vaccine / immunology*
  • Vaccination

Substances

  • Antibodies, Viral
  • Drug Combinations
  • Measles Vaccine
  • Measles-Mumps-Rubella Vaccine
  • Mumps Vaccine
  • Rubella Vaccine